BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 17469202)

  • 21. Splicing-directed therapy in a new mouse model of human accelerated aging.
    Osorio FG; Navarro CL; Cadiñanos J; López-Mejía IC; Quirós PM; Bartoli C; Rivera J; Tazi J; Guzmán G; Varela I; Depetris D; de Carlos F; Cobo J; Andrés V; De Sandre-Giovannoli A; Freije JM; Lévy N; López-Otín C
    Sci Transl Med; 2011 Oct; 3(106):106ra107. PubMed ID: 22030750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hutchinson-Gilford progeria syndrome.
    Pollex RL; Hegele RA
    Clin Genet; 2004 Nov; 66(5):375-81. PubMed ID: 15479179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Status of treatment strategies for Hutchinson-Gilford progeria syndrome with a focus on prelamin: A posttranslational modification.
    Chen X; Yao H; Andrés V; Bergo MO; Kashif M
    Basic Clin Pharmacol Toxicol; 2022 Oct; 131(4):217-223. PubMed ID: 35790078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS.
    Denecke J; Brune T; Feldhaus T; Robenek H; Kranz C; Auchus RJ; Agarwal AK; Marquardt T
    Hum Mutat; 2006 Jun; 27(6):524-31. PubMed ID: 16671095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody.
    McClintock D; Gordon LB; Djabali K
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2154-9. PubMed ID: 16461887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation.
    Verstraeten VL; Broers JL; van Steensel MA; Zinn-Justin S; Ramaekers FC; Steijlen PM; Kamps M; Kuijpers HJ; Merckx D; Smeets HJ; Hennekam RC; Marcelis CL; van den Wijngaard A
    Hum Mol Genet; 2006 Aug; 15(16):2509-22. PubMed ID: 16825282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of LMNA splicing as a strategy to treat prelamin A diseases.
    Lee JM; Nobumori C; Tu Y; Choi C; Yang SH; Jung HJ; Vickers TA; Rigo F; Bennett CF; Young SG; Fong LG
    J Clin Invest; 2016 Apr; 126(4):1592-602. PubMed ID: 26999604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blocking protein farnesylation improves nuclear shape abnormalities in keratinocytes of mice expressing the prelamin A variant in Hutchinson-Gilford progeria syndrome.
    Wang Y; Ostlund C; Worman HJ
    Nucleus; 2010; 1(5):432-9. PubMed ID: 21326826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alteration of splice site selection in the LMNA gene and inhibition of progerin production via AMPK activation.
    Finley J
    Med Hypotheses; 2014 Nov; 83(5):580-7. PubMed ID: 25216752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longwave UV light induces the aging-associated progerin.
    Takeuchi H; Rünger TM
    J Invest Dermatol; 2013 Jul; 133(7):1857-62. PubMed ID: 23392295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing the length of progerin's isoprenyl anchor does not worsen bone disease or survival in mice with Hutchinson-Gilford progeria syndrome.
    Davies BS; Yang SH; Farber E; Lee R; Buck SB; Andres DA; Spielmann HP; Agnew BJ; Tamanoi F; Fong LG; Young SG
    J Lipid Res; 2009 Jan; 50(1):126-34. PubMed ID: 18757838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes.
    Toth JI; Yang SH; Qiao X; Beigneux AP; Gelb MH; Moulson CL; Miner JH; Young SG; Fong LG
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12873-8. PubMed ID: 16129834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment.
    Columbaro M; Capanni C; Mattioli E; Novelli G; Parnaik VK; Squarzoni S; Maraldi NM; Lattanzi G
    Cell Mol Life Sci; 2005 Nov; 62(22):2669-78. PubMed ID: 16261260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced SRSF5 Protein Expression Reinforces Lamin A mRNA Production in HeLa Cells and Fibroblasts of Progeria Patients.
    Vautrot V; Aigueperse C; Oillo-Blanloeil F; Hupont S; Stevenin J; Branlant C; Behm-Ansmant I
    Hum Mutat; 2016 Mar; 37(3):280-91. PubMed ID: 26670336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progerin impairs chromosome maintenance by depleting CENP-F from metaphase kinetochores in Hutchinson-Gilford progeria fibroblasts.
    Eisch V; Lu X; Gabriel D; Djabali K
    Oncotarget; 2016 Apr; 7(17):24700-18. PubMed ID: 27015553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antisense oligonucleotide induction of progerin in human myogenic cells.
    Luo YB; Mitrpant C; Adams AM; Johnsen RD; Fletcher S; Mastaglia FL; Wilton SD
    PLoS One; 2014; 9(6):e98306. PubMed ID: 24892300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisense-Based Progerin Downregulation in HGPS-Like Patients' Cells.
    Harhouri K; Navarro C; Baquerre C; Da Silva N; Bartoli C; Casey F; Mawuse GK; Doubaj Y; Lévy N; De Sandre-Giovannoli A
    Cells; 2016 Jul; 5(3):. PubMed ID: 27409638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Embryonic expression of the common progeroid lamin A splice mutation arrests postnatal skin development.
    McKenna T; Rosengardten Y; Viceconte N; Baek JH; Grochová D; Eriksson M
    Aging Cell; 2014 Apr; 13(2):292-302. PubMed ID: 24305605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of age-related changes in LMNA splicing and expression of progerin in human skeletal muscles.
    Luo YB; Mitrpant C; Johnsen RD; Fabian VA; Fletcher S; Mastaglia FL; Wilton SD
    Int J Clin Exp Pathol; 2013; 6(12):2778-86. PubMed ID: 24294364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MG132 Induces Progerin Clearance and Improves Disease Phenotypes in HGPS-like Patients' Cells.
    Harhouri K; Cau P; Casey F; Guedenon KM; Doubaj Y; Van Maldergem L; Mejia-Baltodano G; Bartoli C; De Sandre-Giovannoli A; Lévy N
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.